Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-989

  1. 7,644 Posts.
    lightbulb Created with Sketch. 1817
    what I find interesting FAR is that the fda gave an interim response (letter) to these lawyers claims (from memory 9 January 2021). An interim response because of the many varied fda priorities. So, really they just responded to acknowledge that there had been a letter sent to them (fda) but have not addressed the contents of the letter (due to being busy). But fda said they would follow up.

    There has been no further correspondence to lawyers from FDA since.

    weird!




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.28
Change
-0.130(5.39%)
Mkt cap ! $2.956B
Open High Low Value Volume
$2.33 $2.35 $2.15 $27.87M 12.24M

Buyers (Bids)

No. Vol. Price($)
39 129882 $2.27
 

Sellers (Offers)

Price($) Vol. No.
$2.28 648 4
View Market Depth
Last trade - 15.24pm 21/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.